Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial
Year: 2017
Type: article
Source: Pancreas
Authors: Marianne Pavel, D. J. Gross, Marta Benavent, M. Caplin, Petros Perros, Rajaventhan Srirajaskanthan, Juan W. Valle, Robert R. Warner, Michael Kulke, Lowell Anthony, Pamela L. Kunz, Dieter Hörsch, Kristian Berg, Pablo Lapuerta, Susanne Jackson, Phillip Banks, Talia Biran, Rocio García‐Carbonero
Institution: Medical Research Council
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2725689981
